A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma

出版年份 2009 全文链接

标题

作者

关键词

出版物

Volume 89, Issue 2, Pages 185-190

出版商

Springer Nature

发表日期

2009-07-24

DOI

10.1007/s00277-009-0793-8

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started